Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel.

H. Döhner, A. Wei, F. Appelbaum, et al. (2022). Blood. Cited 1,921 times. https://doi.org/10.1182/blood.2022016867

2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document.

M. Heuser, S. Freeman, G. Ossenkoppele, et al. (2021). Blood. Cited 457 times. https://doi.org/10.1182/blood.2021013626

Single cell mutation analysis of clonal evolution in myeloid malignancies

Linde A. Miles, R. Bowman, Tiffany R. Merlinsky, et al. (2020). Nature. Cited 371 times. https://doi.org/10.1038/s41586-020-2864-x

Single-cell mutational profiling enhances the clinical evaluation of AML MRD.

A. Ediriwickrema, A. Aleshin, Johannes G. Reiter, et al. (2020). Blood advances. Cited 74 times. https://doi.org/10.1182/bloodadvances.2019001181

Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis

L. Dillon, J. Ghannam, C. Nosiri, et al. (2020). Cancer discovery. Cited 31 times. https://doi.org/10.1101/2020.10.22.20216028